RIL
TNDM icon

Rothschild Investment LLC’s Tandem Diabetes Care TNDM Stock Holding History

Rothschild Investment LLC’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55K Buy
133
+10
+8% +$217 ﹤0.01% 2435
2025
Q4 		$2.7K Buy
123
+98
+392% +$1.77K ﹤0.01% 2212
2025
Q3 		$304 Sell
25
-100
-80% -$1.35K ﹤0.01% 2934
2025
Q2 		$2.33K Buy
125
+95
+317% +$1.88K ﹤0.01% 1969
2025
Q1 		$575 Sell
30
-40
-57% -$1.17K ﹤0.01% 2577
2024
Q4 		$2.52K Buy
70
+20
+40% +$677 ﹤0.01% 1662
2024
Q3 		$2.12K Buy
50
+40
+400% +$1.7K ﹤0.01% 1689
2024
Q2 		$403 Buy
+10
New +$417 ﹤0.01% 2154

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rothschild Investment LLC's TNDM Position: Q1 2026 in Review

Rothschild Investment LLC increased its Tandem Diabetes Care (TNDM) stake by 8.1% in Q1 2026, buying an estimated $217 and bringing the position to 133 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

Rothschild Investment LLC first reported a position in TNDM in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.7K in Q4 2025. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Rothschild Investment LLC held 133 shares of Tandem Diabetes Care worth $2.55K as of Q1 2026.
  • Rothschild Investment LLC bought 10 Tandem Diabetes Care shares in Q1 2026, an estimated $217.
  • Tandem Diabetes Care made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2435 holding.
  • Rothschild Investment LLC first reported a position in Tandem Diabetes Care in Q2 2024 and has held it in 8 quarters since.
  • Rothschild Investment LLC's Tandem Diabetes Care position peaked at $2.7K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.